Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03181308
Title Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Tracon Pharmaceuticals Inc.

lung non-small cell carcinoma


Carotuximab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama, Birmingham Birmingham Alabama 35294 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
*Shaded cells indicate that there was no data available from for the field